Comparison of serum bisphenol a concentrations in mice exposed to bisphenol a through the diet versus oral bolus exposure

Environmental Health Perspectives

Volumn 119, Issue 9, 2011, Pages 1260-1265

  Sieli, Paizlee T ^a   Jašarević, Eldin ^a   Warzak, Denise A ^a   Mao, Jiude ^a   Ellersieck, Mark R ^a   Liao, Chunyang ^b   Kannan, Kurunthachalam ^b   Collet, Séverine H ^c,d   Toutain, Pierre Louis ^c,d   Saal, Frederick S Vom Saal ^a   Rosenfeld, Cheryl S ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Bioavailability; BPA; Chronic exposure; Deconvolution analysis; Endocrine disruptor; Food effect; Oral bolus; Pharmacokinetic analysis

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL;

ABSORPTION; ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; EXPOSURE; FEMALE; FIRST PASS EFFECT; LIVER METABOLISM; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXICOKINETICS;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, LIQUID; DIET; ENDOCRINE DISRUPTORS; FEMALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; PHENOLS; TANDEM MASS SPECTROMETRY;

ANIMALIA; MUS;

EID: 79960985284     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1003385     Document Type: Article

References (38)

1. Bailin PS, Byrne M, Lewis S, Liroff R. 2008. Public Awareness Drives Market for Safer Alternatives: Bisphenol A Market Analysis Report. Available: http://www.iehn.org/publications.reports.bpa.php [accessed 20 April 2011].
2. Balakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD. 2010. Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 202(4):393.e1-7.
3. Biedermann S, Tschudin P, Grob K. 2010. Transfer of bisphenol A from thermal printer paper to the skin. Anal Bioanal Chem 398(1):571-576.
4. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116:39-44.
5. Cox KH, Gatewood JD, Howeth C, Rissman EF. 2010. Gestational exposure to bisphenol A and cross-fostering affect behaviors in juvenile mice. Horm Behav 58(5):754-761.
6. Dekant W, Volkel W. 2008. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 228(1):114-134.
7. Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW. 2010a. Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats. Toxicol Appl Pharmacol 247(2):158-165.
8. Doerge DR, Twaddle NC, Woodling KA, Fisher JW. 2010b. Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys. Toxicol Appl Pharmacol 248(1):1-11.
9. Dolinoy DC, Huang D, Jirtle RL. 2007. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 104(32):13056-13061.
10. Environment Canada. 2008. Screening Assessment forthe Challenge Phenol, 4,4'-(1-methylethylidene) bis-(Bisphenol A). Chemical Abstracts Service Registry Number 80-05-7. Available: http://www.ec.gc.ca/substances/ese/eng/challenge/batch2/batch2_80-05-7.cfm [accessed 18 March 2011].
11. FDA (Food and Drug Administration). 2008. Food and Drug Administration Draft Assessment of Bisphenol A for Use in Food Contact Applications, 14 August 2008. Available: http://www.fda.gov/ohrms/dockets/AC/08/briefing/2008-0038b1_01_02_FDA%20BPA%20Draft%20Assessment.pdf [accessed 1 August 2011].
12. Food and Agriculture Organization of the United Nations and the World Health Organization. 2010. Joint FAO/WHO Expert Meeting to Review Toxicological and Health Aspects of Bisphenol A. Available: http://www.who.int/foodsafety/chem/chemicals/bisphenol_release/en/index.html [accessed 1 August 2011].
13. Galloway T, Cipelli R, Guralnik J, Ferrucci L, Bandinelli S, Corsi AM, et al. 2010. Daily bisphenol A excretion and associations with sex hormone concentrations: results from the InCHIANTI adult population study. Environ Health Perspect 118:1603-1608.
14. Gies A, Heinzow B, Dieter HH, Heindel J. 2009. Bisphenol A workshop of the German Federal Environment Agency-March 30-31, 2009: work group report: public health issues of bisphenol A. Int J Hyg Environ Health 212(6):693-696.
15. Hanioka N, Takeda Y, Tanaka-Kagawa T, Hayashi K, Jinno H, Narimatsu S. 2008. Interaction of bisphenol A with human UDP-glucuronosyltransferase 1A6 enzyme. Environ Toxicol 23(3):407-412.
16. He Y, Miao M, Herrinton LJ, Wu C, Yuan W, Zhou Z, et al. 2009. Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels. Environ Res 109(5):629-633.
17. Inoue H, Tsuruta A, Kudo S, Ishii T, Fukushima Y, Iwano H, et al. 2005. Bisphenol A glucuronidation and excretion in liver of pregnant and nonpregnant female rats. Drug Metab Dispos 33(1):55-59.
18. Institute of Laboratory Animal Resources 1996. Guide for the Care and Use of Laboratory Animals. 7th ed. Washington, DC: National Academy Press.
19. Kavaliers M, Hirst M, Teskey GC. 1985. Nocturnal feeding in the mouse-opiate and pineal influences. Life Sci 36(10):973-980.
20. Kurebayashi H, Betsui H, Ohno Y. 2003. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Toxicol Sci 73(1):17-25.
21. Matsumoto A, Kunugita N, Kitagawa K, Isse T, Oyama T, Foureman GL, et al. 2003. Bisphenol A levels in human urine. Environ Health Perspect 111:101-104.
22. Nepomnaschy PA, Baird DD, Weinberg CR, Hoppin JA, Longnecker MP, Wilcox AJ. 2009. Within-person variability in urinary bisphenol A concentrations: measurements from specimens after long-term frozen storage. Environ Res 109(6):734-737.
23. Padmanabhan V, Siefert K, Ransom S, Johnson T, Pinkerton J, Anderson L, et al. 2008. Maternal bisphenol-A levels at delivery: a looming problem? J Perinatol 28(4):258-263.
24. Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter JM. 2000. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 54(1):3-18.
25. Sakamoto H, Yokota H, Kibe R, Sayama Y, Yuasa A. 2002. Excretion of bisphenol A-glucuronide into the small intestine and deconjugation in the cecum of the rat. Biochim Biophys Acta 1573(2):171-176.
26. Stahlhut RW, Welshons WV, Swan SH. 2009. Bisphenol A data in NHANES suggest longer than expected half-life, substantial non-food exposure, or both. Environ Health Perspect 117:784-789.
27. Tam YK. 1993. Individual variation in first-pass metabolism. Clin Pharmacokinet 25(4):300-328.
28. Taylor JA, Vom Saal FS, Welshons WV, Drury B, Rottinghaus G, Hunt PA, et al. 2011. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect 119:422-430.
29. Teeguarden JG, Calafat AM, Ye X, Doerge DR, Churchwell MI, Gunawan R, et al. 2011. 24-Hour human urine and serum profiles of bisphenol A during high dietary exposure. Toxicol Sci doi:10.1093/toxsci/kfr160 [Online 24 June 2011].
30. Tominaga T, Negishi T, Hirooka H, Miyachi A, Inoue A, Hayasaka I, et al. 2006. Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC-MS/mS method. Toxicology 226(2-3):208-217.
31. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. 2010a. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 118:1055-1070.
32. Vandenberg LN, Chahoud I, Padmanabhan V, Paumgartten FJ, Schoenfelder G. 2010b. Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ Health Perspect 118:1051-1054.
33. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. 2007. Human exposure to bisphenol A (BPA). Reprod Toxicol 24(2):139-177.
34. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. 2009. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30(1):75-95.
35. Volkel W, Colnot T, Csanady GA, Filser JG, Dekant W. 2002. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 15(10):1281-1287.
36. vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, et al. 2007. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24(2):131-138.
37. Wilkinson GR. 1997. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans. Adv Drug Deliv Rev 27(2-3):129-159.
38. Willhite CC, Ball GL, McLellan CJ. 2008. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration. J Toxicol Environ Health B Crit Rev 11(2):69-146.